Sacral neuromodulation (SNM) is safe for patients with refractory lower urinary tract dysfunction and yields high patient satisfaction, according to a study published online Sept. 9 in the Scandinavian Journal of Urology.
Hanne Kobberø, from Odense University Hospital in Denmark, and colleagues offered 22 patients with refractory idiopathic and neurogenic lower urinary tract dysfunction a two-stage test procedure and SNM device implantation. Patients rated their satisfaction with treatment using a 5-point Likert scale and completed a bother score of urinary, phenergan oral liquid bowel, and sexual symptoms (on a scale of 1 to 10, with 10 being the worst).
Nineteen of the patients were responders and had the pulse generator implanted. The researchers found that 17 patients were very satisfied/satisfied. In idiopathic and neurogenic patients, there was a significant change in urinary symptoms bother score, from 10 to 4 and 10 to 3, respectively. Eleven of the patients had symptoms from two or three pelvic compartments. Complications occurred in nine patients, with resolution of all but one.
Source: Read Full Article